These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26336130)

  • 1. Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis.
    Chen YP; Zhang WN; Chen L; Tang LL; Mao YP; Li WF; Liu X; Zhou GQ; Sun Y; Kang TB; Zeng MS; Liu N; Ma J
    Oncotarget; 2015 Oct; 6(30):29311-23. PubMed ID: 26336130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STRUCTURAL AND FUNCTIONAL CHARACT ERISTICS OF THE LMP1 ONCOGENE IN PATIENTS WITH TUMORS ASSOCIATED AND NOT ASSOCIATED WITH THE EPSTEIN-BARR VIRUS.
    Senyuta NB; Smirnova KV; Diduk SV; Goncharova EV; Shcherbak LN; Gurtsevitch VE
    Mol Gen Mikrobiol Virusol; 2016 Sep; 34(2):71-75. PubMed ID: 30380210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
    Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
    Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
    Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
    J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.
    Hashmi AA; Hussain ZF; Hashmi KA; Zafar MI; Edhi MM; Faridi N; Khan M
    World J Surg Oncol; 2017 Apr; 15(1):89. PubMed ID: 28427406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
    Tao Y; Song X; Deng X; Xie D; Lee LM; Liu Y; Li W; Li L; Deng L; Wu Q; Gong J; Cao Y
    Exp Cell Res; 2005 Feb; 303(2):240-51. PubMed ID: 15652339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.
    Wang A; Zhang W; Jin M; Zhang J; Li S; Tong F; Zhou Y
    Mol Med Rep; 2016 May; 13(5):4151-8. PubMed ID: 27052804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
    Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling.
    Morris MA; Dawson CW; Laverick L; Davis AM; Dudman JP; Raveenthiraraj S; Ahmad Z; Yap LF; Young LS
    Sci Rep; 2016 Jan; 6():19533. PubMed ID: 26782058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma.
    Vockerodt M; Vrzalikova K; Ibrahim M; Nagy E; Margielewska S; Hollows R; Lupino L; Tooze R; Care M; Simmons W; Schrader A; Perry T; Abdullah M; Foster S; Reynolds G; Dowell A; Rudzki Z; Krappmann D; Kube D; Woodman C; Wei W; Taylor G; Murray PG
    J Pathol; 2019 Jun; 248(2):142-154. PubMed ID: 30666658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
    Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
    Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.